Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Nishikawa

Showing results (91-100 of 197) with videos related to

Pageof 20
Sort By:
Cancer Research|February 10, 2012
Intracellular tumor-associated antigens represent effective targets for passive immunotherapyTakuro Noguchi, Takuma Kato, Linan Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 25, 2010
Peptide vaccine induces enhanced tumor growth associated with apoptosis induction in CD8+ T cellsDaisuke Muraoka, Takuma Kato, Linan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2005
Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hostsHiroyoshi Nishikawa, Takuma Kato, Isao Tawara, et al.
International Journal of Cancer|October 28, 2016
ICOS<sup>+</sup> Foxp3<sup>+</sup> TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pyloriHirotsugu Nagase, Tomohira Takeoka, Shinya Urakawa, et al.
Science Translational Medicine|February 12, 2025
Coactivation of innate immune suppressive cells induces acquired resistance against combined TLR agonism and PD-1 blockadeHitomi Nishinakamura, Sayoko Shinya, Takuma Irie, et al.
Science Immunology|February 2, 2020
Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i>-mutated non-small cell lung cancerEri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi, et al.
Nagoya Journal of Medical Science|December 29, 2023
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantationNaoya Katsuyama, Takakazu Kawase, Carolyne Barakat, et al.
International Immunology|November 4, 2025
KRAS mutations disrupt interactions between CD8+ T cells and antigen-presenting cells in the tumor microenvironment of biliary tract cancerFumihiro Terasaki, Shogo Kumagai, Akito Fukuda, et al.
Cell Reports|February 16, 2024
Stem-like progenitor and terminally differentiated T<sub>FH</sub>-like CD4<sup>+</sup> T cell exhaustion in the tumor microenvironmentWenhao Zhou, Shusuke Kawashima, Takamasa Ishino, et al.
Nagoya Journal of Medical Science|December 17, 2021
Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumorsTakuro Saito, Koji Kurose, Takashi Kojima, et al.
Pageof 20

Showing results (91-100 of 197) with videos related to

Sort By:
Pageof 20
Cancer Research|February 10, 2012
Intracellular tumor-associated antigens represent effective targets for passive immunotherapyTakuro Noguchi, Takuma Kato, Linan Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 25, 2010
Peptide vaccine induces enhanced tumor growth associated with apoptosis induction in CD8+ T cellsDaisuke Muraoka, Takuma Kato, Linan Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2005
Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hostsHiroyoshi Nishikawa, Takuma Kato, Isao Tawara, et al.
International Journal of Cancer|October 28, 2016
ICOS<sup>+</sup> Foxp3<sup>+</sup> TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pyloriHirotsugu Nagase, Tomohira Takeoka, Shinya Urakawa, et al.
Science Translational Medicine|February 12, 2025
Coactivation of innate immune suppressive cells induces acquired resistance against combined TLR agonism and PD-1 blockadeHitomi Nishinakamura, Sayoko Shinya, Takuma Irie, et al.
Science Immunology|February 2, 2020
Blockade of EGFR improves responsiveness to PD-1 blockade in <i>EGFR</i>-mutated non-small cell lung cancerEri Sugiyama, Yosuke Togashi, Yoshiko Takeuchi, et al.
Nagoya Journal of Medical Science|December 29, 2023
T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantationNaoya Katsuyama, Takakazu Kawase, Carolyne Barakat, et al.
International Immunology|November 4, 2025
KRAS mutations disrupt interactions between CD8+ T cells and antigen-presenting cells in the tumor microenvironment of biliary tract cancerFumihiro Terasaki, Shogo Kumagai, Akito Fukuda, et al.
Cell Reports|February 16, 2024
Stem-like progenitor and terminally differentiated T<sub>FH</sub>-like CD4<sup>+</sup> T cell exhaustion in the tumor microenvironmentWenhao Zhou, Shusuke Kawashima, Takamasa Ishino, et al.
Nagoya Journal of Medical Science|December 17, 2021
Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumorsTakuro Saito, Koji Kurose, Takashi Kojima, et al.
Pageof 20